The Patent Finder

Creagene Inc.

Also on record
Records under this name other than patents Creagene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Creagene Inc.

PatentTitleStatus Expires Confidence
US 8,513,028Use of MLN51 gene and protein
Lapsed on the fee record
Ended Aug 20, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 20, 2025From the USPTO record
US 7,138,274Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)
Term ended
Term ended Aug 31, 2024 · From the USPTO record
Term endedTerm ended Aug 31, 2024From the USPTO record
US 7,101,844Cytoplasmic transduction peptides and uses thereof
Term ended
Term ended Mar 28, 2023 · From the USPTO record
Term endedTerm ended Mar 28, 2023From the USPTO record
US 6,780,618Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirus
Lapsed on the fee record
Ended Aug 24, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 24, 2016From the USPTO record
US 6,696,289Replication-competent recombinant Sabin type 1 strain of poliovirus
Lapsed on the fee record
Ended Feb 24, 2016 · From the USPTO record
Lapsed on the fee recordEnded Feb 24, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited